Events

Vitae Pharmaceuticals to present at UBS Global Life Sciences Conference in New York on September 21, 2010.

Vitae Pharmaceuticals to present at Stifel Nicolaus Healthcare Conference in Boston on September 15, 2010.

News

July 14, 2010
Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer

June 29, 2010
Vitae Pharmaceuticals Receives $14 Million Milestone Payment as Boehringer Ingelheim Advances Lead Compound into Phase I Clinical Trials

November 11, 2009
Vitae Pharmaceuticals to Present at Windhover's Annual Therapeutic Area Partnerships Conference

September 29, 2009
Vitae Pharmaceuticals Receives $8 Million Payment from Boehringer Ingelheim for Achievement of 11beta-HSD-1 Program Milestone

June 15, 2009
Boehringer Ingelheim and Vitae Pharmaceuticals announce a major collaboration to research and develop novel treatments for Alzheimer's disease

October 28, 2008
Vitae Pharmaceuticals Secures $13 Million In Debt Financing

March 5, 2008
Vitae Pharmaceuticals Appoints Richard Gregg, M.D. as Chief Scientific Officer

October 15, 2007
Vitae Pharmaceuticals and Boehringer Ingelheim Announce a Major Collaboration to Develop and Commercialize Novel Treatments for Diabetes and Metabolic Diseases